Surfactant in respiratory distress syndrome

  • D. Vidyasagar
Part of the Topics in Anaesthesia and Critical Care book series (TIACC)


Great deal of progress has been made since the first successful report of the use of surfactant in respiratory distress syndrome (RDS) by Fujiwara in 1980 [1]. Since then scores of randomized clinical trials involving thousands of infants in different countries have been conducted. Indeed the science of clinical research of multicentered trials evolved during the last 20 years, thanks to interest in RDS.


Respiratory Distress Syndrome Patent Ductus Arteriosus Mean Arterial Blood Pressure Surfactant Protein Nasal Continuous Positive Airway Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fujiwara T, Chida S, Watabe YJ et al (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1:55–59PubMedCrossRefGoogle Scholar
  2. 2.
    King RJ (1982) Pulmonary surfactant. J Appl Physiol 53:1–8PubMedCrossRefGoogle Scholar
  3. 3.
    Harwood JL (1987) Lung surfactant. Prog Lipid Res 26:211–256PubMedCrossRefGoogle Scholar
  4. 4.
    Haagsman HP et al (1991) Synthesis and assembly of lung surfactant. Ann Rev Physio 53:441–464CrossRefGoogle Scholar
  5. 5.
    Hawgwood S, Shiffer K (1991) Structures and properties of the surfactant associated proteins. Ann Rev Physiol 53:375–394CrossRefGoogle Scholar
  6. 6.
    Cochrane CG, Revak SD, Merritt TA et al (1996) The efficacy and safety of KL4 surfactant in preterm infants with RDS. Am J Resp Crit Care Med 153:404–410PubMedGoogle Scholar
  7. 7.
    Morley CJ, Bangham AD, Miller N et al (1981) Dry artificial surfactant and its effect on very premature babies. Lancet 1:64–68PubMedCrossRefGoogle Scholar
  8. 8.
    Halliday H, McClune G, Reid MC et al (1984) Controlled trial of artificial surfactant to prevent respiratory distress syndrome. Lancet 1:476–478PubMedCrossRefGoogle Scholar
  9. 9.
    Hallman M, Merritt TA, Jarvenpoa AL et al (1985) Exogenous human surfactant for treatment of severe respiratory distress syndrome. A randomized prospective clinical trial. J Pediatr 106:963–969.PubMedCrossRefGoogle Scholar
  10. 10.
    Robertson B (1988) Surfactant replacement therapy for severe RDS. An international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics 82:683–691Google Scholar
  11. 11.
    Long W, Corbet A, Colton R et al (1991) A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. N Engl J Med 325:1696–1703PubMedCrossRefGoogle Scholar
  12. 12.
    Raju TNK, Vidyasagar D, Bhat R et al (1987) Double blind controlled trial of single dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet 1:651–656PubMedCrossRefGoogle Scholar
  13. 13.
    Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328:861–868PubMedCrossRefGoogle Scholar
  14. 14.
    Raju TNK, Langenberg P (1993) Pulmonary hemorrhage and exogenous surfactant therapy. A meta analysis. J Pediatr 123:603–610PubMedCrossRefGoogle Scholar
  15. 15.
    Pappin A, Shenker N, Hack M et al (1994) Extensive intra alveolar pulmonary hemorrhage in infants dying after surfactant therapy. J Pediatr 124:621–626PubMedCrossRefGoogle Scholar
  16. 16.
    Ferrara TB, Hoekstra RE, Couser RJ et al (1994) Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy. J Pediatr 124:119–124PubMedCrossRefGoogle Scholar
  17. 17.
    Survanta Multidose Study Group (1994) Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. J Pediatr 124:962–67CrossRefGoogle Scholar
  18. 18.
    Soll RF (1997) Surfactant therapy in the USA: trials and current routines. Biol Neonate 71(Suppl 1):1–7PubMedGoogle Scholar
  19. 19.
    Corbet A, Gerdes J, Long W et al (1995) Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700–1100 grams: effects on mortality rate. J Pediatr 126:969–978PubMedCrossRefGoogle Scholar
  20. 20.
    Verder H, Robertson B, Greison G et al (1994) Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 331:1051–1055PubMedCrossRefGoogle Scholar
  21. 21.
    Centers for Disease Control (1993) Infant mortality-United States in 1990. MMWR 42:161–165Google Scholar
  22. 22.
    Vermont-Oxford Neonatal Network (1996) A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 97:1–6Google Scholar
  23. 23.
    Halliday HL (1997) Clinical trials of surfactant replacement in Europe. Biol Neonate 71(Suppl 1):8–12PubMedCrossRefGoogle Scholar
  24. 24.
    Rossello JD, Hayward PE, Martell M, Del Barco M, Margotto P, Grandzoto J, Bastida J, Pena J, Villaneuva D (1997) Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources. J Perinat Med 25(3):280–287PubMedGoogle Scholar
  25. 25.
    Davies VA, Ballot DE, Rothberg AD (1995) The cost and effectiveness of surfactant replacement therapy at Johannesburg Hospital, November 1991-December 1992. S Afr Med J 85(7):649Google Scholar
  26. 26.
    Ballot DE, Rothberg AD, Davies VA (1995) The selection of infants for surfactant replacement therapy under conditions of limited financial resources. S Afr Med J 85(7):640–643PubMedGoogle Scholar
  27. 27.
    Davies VA, Rothberg AD, Ballot DE (1995) The introduction of surfactant replacement therapy into South Africa. S Afr Med J 85(7):637–640PubMedGoogle Scholar
  28. 28.
    Moen A (1997) Circulatory effects of surfactant therapy. Biol Neonate 71(Suppl 1):18–22PubMedCrossRefGoogle Scholar
  29. 29.
    Vidyasagar D, Maeta H, Raju TNK, John E, Bhat R, Go M et al (1985) Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease. Pediatrics 75:1132–1142PubMedGoogle Scholar
  30. 30.
    Fujiwara T, Konishi M, Chida S et al (1990) Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome. Final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. Pediatrics 86:753–764PubMedGoogle Scholar
  31. 31.
    Todd DA, Choukroun ML, Fayon M, Kays C, Guenard H, Galperine I, Demarquez JL (1995) Respiratory mechanics before and after late artificial surfactant rescue. J Paediatr Child Health 31(6):532–536PubMedCrossRefGoogle Scholar
  32. 32.
    Sandberg KL, Lindstrom DP, Sjoqvist BA, Parker RA, Cotton RB (1997) Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome. Pediatr Pulmonol 24:337–343PubMedCrossRefGoogle Scholar
  33. 33.
    Bhat R, Dziedzic K, Vidyasagar D (1990) Effect of single dose surfactant TA on pulmonary function. Crit Care Med 18:590–595PubMedCrossRefGoogle Scholar
  34. 34.
    Bhat R, John E, Diaz-Blanco J, Ortega R, Fornell L, Vidyasagar D (1989) Surfactant therapy and spontaneous diuresis. J Pediatr 114:443–447PubMedCrossRefGoogle Scholar
  35. 35.
    Weaver TE (1991) Surfactant proteins and SP-D. Am J Respir Cell Mol Biol 5:4–5PubMedGoogle Scholar
  36. 36.
    The OSIRIS Collaborative Group (1992) Early versus delayed neonatal administration of synthetic surfactant — the judgement of OSIRIS. Lancet 340:1363–1369CrossRefGoogle Scholar
  37. 37.
    Corbet A, Gerdes J, Long W et al (1995) Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. J Pediatr 126:969–978PubMedCrossRefGoogle Scholar
  38. 38.
    Costakos D, Allen D, Krauss A, Ruiz N, Fluhr K, Stouvenel A et al (1996) Surfactant therapy prior to the interhospital transport of preterm infants. Am J Perinat 13(5):309–316CrossRefGoogle Scholar
  39. 39.
    Bhuta T, Walker K, Jones N, Halliday R, Berry A (1995) Surfactant administration by newborn emergency transport service. Proceedings of the thirteenth annual Congress of the Australian Perinatal Society, AucklandGoogle Scholar
  40. 40.
    Khammash H, Perlman M, Wojtulewicz J et al (1993) Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 92:135–139PubMedGoogle Scholar
  41. 41.
    Halliday HL, Speer CP, Robertson B (1996) Treatment of severe meconium aspiration syndrome with porcine surfactant. Eur J Pediatr 155:1047–1051PubMedCrossRefGoogle Scholar
  42. 42.
    Findlay RD, Taeusch HW, Walther FJ (1996) Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97:48–52PubMedGoogle Scholar
  43. 43.
    Paranka MS, Walsh WF, Stancombe BB (1992) Surfactant lavage in a piglet model of meconium aspiration syndrome. Pediatr Res 31:625–628PubMedCrossRefGoogle Scholar
  44. 44.
    Revak SD, Cochrane CG, Merritt TA (1997) The therapeutic effect of bronchoalveolar lavage with KL4-surfactant in animal models of meconium aspiration syndrome. Pediatr Res 41:A265CrossRefGoogle Scholar
  45. 45.
    Herting E, Jarstrand C, Rasool O et al (1994) Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 36:784–791PubMedCrossRefGoogle Scholar
  46. 46.
    Sherman MP, Campbell LA, Merritt TA et al (1994) Effect of different surfactant on pulmonary group B streptococcal infections in premature rabbits. J Pediatr 125:939–947PubMedCrossRefGoogle Scholar
  47. 47.
    Walmrath D, Gunther A, Ghofrani HA et al (1996) Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 154:57–62PubMedGoogle Scholar
  48. 48.
    Anzueto A, Baughman RP, Guntupalli KK (1996) Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 334:1417–1421PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • D. Vidyasagar

There are no affiliations available

Personalised recommendations